Sigma Planning Corp’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-50
Closed -$12K 1055
2019
Q1
$12K Buy
50
+1
+2% +$252 ﹤0.01% 938
2018
Q4
$11K Sell
49
-474
-91% -$119K ﹤0.01% 851
2018
Q3
$144K Hold
523
0.01% 902
2018
Q2
$176K Sell
523
-32
-6% -$10.5K 0.01% 839
2018
Q1
$137K Sell
555
-100
-15% -$29.2K 0.01% 809
2017
Q4
$211K Buy
655
+152
+30% +$56.5K 0.02% 756
2017
Q3
$268K Buy
503
+102
+25% +$54.3K 0.02% 648
2017
Q2
$253K Buy
401
+48
+14% +$32.3K 0.02% 625
2017
Q1
$269K Buy
353
+72
+26% +$57K 0.03% 607
2016
Q4
$229K Buy
281
+132
+89% +$105K 0.03% 596
2016
Q3
$135K Buy
149
+57
+62% +$55.8K 0.02% 697
2016
Q2
$83K Buy
+92
New +$61.7K 0.01% 676

Other funds holding VIVS

Sigma Planning Corp's VIVS Position: Q2 2019 in Review

Sigma Planning Corp sold out of VivoSim Labs (VIVS) in Q2 2019, closing a stake of 50 shares — an estimated $12K sold.

Sigma Planning Corp first reported a position in VIVS in Q2 2016 and held it in 12 quarters. The position peaked at $269K in Q1 2017. 93 funds tracked by Wall St. Rank hold VIVS as of Q2 2019.

  • Sigma Planning Corp reported no remaining VivoSim Labs position as of Q2 2019 after selling out during the quarter.
  • Sigma Planning Corp sold 50 VivoSim Labs shares in Q2 2019, an estimated $12K.
  • Sigma Planning Corp first reported a position in VivoSim Labs in Q2 2016 and held it in 12 quarters.
  • Sigma Planning Corp's VivoSim Labs position peaked at $269K in Q1 2017.
  • 93 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2019.

Based on Sigma Planning Corp's 13F filing for Q2 2019, filed 1 Aug 2019.